To explore IL-15-mediated anti-glioma immunity, we treated HMC3 and BV2 microglia cells using Ad5-GFP, Ad5-Ki67/GFP and Ad5-Ki67/IL-15. The gene discussed is IL15; the disease is central nervous system cancer.